Cannabinol and cannabidiol exert opposing effects on rat feeding patterns

Psychopharmacology

Volumn 223, Issue 1, 2012, Pages 117-129

  Farrimond, Jonathan A ^a   Whalley, Benjamin J ^a   Williams, Claire M ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Appetite; Behavio(u)r; Cannabidiol; Cannabigerol; Cannabinol; Cannabis; Feeding; Phytocannabinoids

Indexed keywords

CANNABIDIOL; CANNABIGEROL; CANNABINOID; CANNABINOL; RIMONABANT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; BODY WEIGHT; CONTROLLED STUDY; DECREASED APPETITE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; FEEDING BEHAVIOR; FOOD INTAKE; INCREASED APPETITE; LATENT PERIOD; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SATIETY;

ANIMALS; CANNABIDIOL; CANNABINOID RECEPTOR ANTAGONISTS; CANNABINOIDS; CANNABINOL; EATING; FEEDING BEHAVIOR; MALE; PIPERIDINES; PYRAZOLES; RATS; RECEPTOR, CANNABINOID, CB1; TIME FACTORS;

EID: 84865128216     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2697-x     Document Type: Article

References (52)

1. Abel E (1975) Cannabis: effects on hunger and thirst. Behav Biol 15:255
2. Amar B (2006) Cannabinoids in medicine: a review of their therapeutic potential. J Ethnopharmacol 105:1-25
3. Bayewitch M, Rhee MH, Avidor-Reiss T, Breuer A, Mechoulam R, Vogel Z (1996) (-)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase. J Biol Chem 271:9902-9905 (Pubitemid 26131542)
4. BNF (2006) British National Formulary. BMJ Publishing Group, London
5. Cadoni C, Pisanu A, Solinas M, Acquas E, Di Chiara G (2001) Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology 158(3):259-266 (Pubitemid 33071163)
6. Cascio MG, Gauson LA, Stevenson LA, Ross RA, Pertwee RG (2010) Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist. Br J Pharmacol 159:129-141
7. Clark RT (2009) Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended December 31, 2008 United States Securities and Exchange Commission. Merck & Co., Inc., Washington
8. De Filippis Dea (2008) Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB1 receptors and fatty acid amide hydrolase. Neurogastroenterol Motil 20:919-927 (Pubitemid 352019711)
9. 9-tetrahydrocannabivaron (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour. Psychopharmacol 219:859-873
10. Devane W, Dysarz F, Johnson MR, Melvin LS, Howlett A (1988) Determination and characterisation of a cannabinoid receptor in the rat brain. Mol Pharmacol 34:605-613 (Pubitemid 19007296)
11. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949 (Pubitemid 23026736)
12. EMA (2009) Procedural steps taken and scientific information after the authorisation Acomplia. In: Agency EM (ed) EMEA/H/C/000666/A20/0012. European Union, Brussels
13. Evans AT, Formukong E, Evans FJ (1987) Activation of phospholipase A2 by cannabinoids: lack of correlation with CNS effects. FEBS Lett 211:119-122 (Pubitemid 17049437)
14. Farrimond J, Hill A, Whalley B, Williams C (2010a) Cannabis constituents modulate 9-tetrahydrocannabinol-induced hyperphagia in rats. Psychopharmacology 210:97-106
15. Farrimond JA, Whalley BJ, Williams CM (2010b) A low Δ 9tetrahydrocannabinol cannabis extract induces hyperphagia in rats. Behav Pharmacol 21:769-773
16. Farrimond JA, Mercier MS, Whalley BJ, Williams CM (2011) Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation. Phytother Res 25:18
17. Farrimond JA, Whalley BJ, Williams CM (2012) Non- Δ9tetrahydrocannabinol phytocannabinoids are effective modulators of rat feeding patterns in vivo. Behav Pharmacol 23:113 - 117
18. Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, Lai Y, Ma AL, Mitchell RL (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48:443-450
19. Gaoni Y, Mechoulam R (1964) Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc 86:1646-1647
20. Gauson L, Stevenson L, Thomas A, Baillie G, Ross R, Pertwee R (2007) Cannabigerol behaves as a partial agonist at both CB1 and CB2 receptors. Symposium on the Cannabinoids. International Cannabinoid Research Society, Burlington, Vermont, USA, 206 pp
21. Glass M (2001) The role of cannabinoids in neurodegenerative diseases. Progress in Neuro-psychopharmacology and Biological Psychiatry 25:743-765 (Pubitemid 32374965)
22. Hao S, Avraham Y, Mechoulam R, Berry EM (2000) Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. Eur J Pharmacol 392:147-156 (Pubitemid 30184903)
23. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11:563-583
24. Hill A, Williams C, Whalley B, Stephens G (2012) Phytocannabinoids as novel therapeutic agents in CNS disorders. Pharmacol Ther 133:79-97
25. Ignatowska-Jankowska B, Jankowski M, Swiergiel A (2010) Cannabidiol decreases body weight gain in rats: involvement of CB2 receptors. Neurosci Lett 490:82-84
26. Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R (2009) Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci 30:515-527
27. Jamshidi N, Taylor DA (2001) Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol 134:1151-1154 (Pubitemid 33097243)
28. Koch JE, Matthews SM (2001) 9-Tetrahydrocannabinol stimulates palatable food intake in Lewis rats: effects of peripheral and central administration. Nutr Neurosci 4:179-187 (Pubitemid 34071737)
29. Ligresti A, Moriello A, Starowicz K, Matias I, Pisanti S, De Petrocellis L, Laezza C, Portella G, Bifulco M, Di Marzo V (2006) Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther 318:1375 (Pubitemid 44268348)
30. Martin BR, Balster RL, Razdan RK, Harris LS, Dewey WL (1981) Behavioral comparisons of the stereoisomers of tetrahydrocannabinols. Life Science 29:565-574 (Pubitemid 11030909)
31. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564 (Pubitemid 20238806)
32. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83-90
33. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65 (Pubitemid 23305569)
34. O'Shaughnessey WB (1843) On the Preparations of the Indian hemp, or gunjah (Cannabis indica): their effects on the animal system in health, and their utility in the treatment of tetanus and other convulsive diseases. Provincial Medical Journal 5
35. 9-tetrahydrocannabivarin. Br J Pharmacol 153:199-215
36. Petrosino S, Ligresti A, Di Marzo V (2009) Endocannabinoid chemical biology: a tool for the development of novel therapies. Curr Opin Chem Biol 13:309-320
37. Pryce G, Ahmed Z, Hankey D, Jackson S, Croxford J, Pocock J, Ledent C, Petzold A, Thompson A, Giovannoni G, Cuzner M, Baker D (2003) Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain 126:2191-2202 (Pubitemid 37432364)
38. Rhee MH, Vogel Z, Barg J, Bayewitch M, Levy R, Hanus L, Breuer A, Mechoulam R (1997) Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase. J Med Chem 40:3228-3233 (Pubitemid 27413747)
39. Riedel G, Fadda P, McKillop-Smith S, Pertwee R, Platt B, Robinson L (2009) Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice. Br J Pharmacol 156:1154-1166
40. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C et al (1999) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350(2-3):240-244
41. Rubino T, Viganò D, Massi P, Parolaro D (2001) The psychoactive ingredient of marijuana induces behavioural sensitization. Eur J Neurosci 14(5):884-886
42. 2+ levels. J Neurosci 29:2053-2063
43. Scopinho AA, Guimaraes FS, Correa F, Resstel L (2011) Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists. Pharmacol Biochem Behav 98:268-272
44. Sofia RD, Knobloch LC (1976) Comparative effects of various naturally occurring cannabinoids on food, sucrose and water consumption by rats. Pharmacol Biochem Behav 4:591-599
45. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89-97
46. Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, Rössner S (2005) Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe Study. Lancet 365:1389-1397 (Pubitemid 40523733)
47. Wang T, Collet J, Shapiro S, Ware M (2008) Adverse effects of medical cannabinoids: a systematic review. Can Med Assoc J 178:1669 (Pubitemid 351899653)
48. Wiley J, Burston J, Leggett D, Alekseeva O, Razdan R, Mahadevan A, Martin B (2005) CB1 cannabinoid receptor-mediated modulation of food intake in mice. Br J Pharmacol 145:293-300 (Pubitemid 40896074)
49. 1 receptors. Psychopharmacology 143:315-317 (Pubitemid 29204987)
50. Williams CM, Kirkham TC (2002a) Observational analysis of feeding induced by Delta9-THC and anandamide. Physiology and Behaviour 76:241-250 (Pubitemid 34607232)
51. 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav 71:333-340 (Pubitemid 34102496)
52. 9-THC. Physiol Behav 65:343-346 (Pubitemid 28548657)